Bone Healing
-
Common Orthopedic Issues in Veterinary Medicine
White Paper: Common Orthopedic Issues in Veterinary Medicine Introduction Orthopedic disorders are among the most prevalent health concerns in veterinary medicine, affecting companion animals, equine patients, and livestock. These conditions range from congenital deformities to acquired injuries and degenerative diseases, significantly impacting an animal’s mobility and quality of life. This white paper explores the most…
-
Release Of Our Very First OssiVet® Order!
The PBC Biovet Operations Team has reached a significant milestone with the preparation and release of our very first OssiVet® order! OssiVet®, our innovative veterinary bioadhesive bone substitute, is designed to support advanced orthopedic care for companion animals, combining safety, efficacy, and ease of use. This landmark achievement is a testament to our team’s hard…
-
Accelerating new Medical Innovations: OTA Showcase
PBC Biomed are ready for action at the Orthopaedic Trauma Association meeting in Montreal! Stop by booth #431 to meet our team and learn more about our new #innovations, powered by our Accelerating Innovation Model ‘AIM’. #acceleratingmedicalinnovation #biomaterials #newinnovations
-
PBC Biomed OTA Symposium – Strengthening the Bond: Modern Biomaterials for Fracture Fixation and Bone Regeneration.
We are delighted to announce that we will be continuing our ‘Strengthening the Bond’ education series at the Orthopaedic Trauma Association meeting in Montreal this week. Strengthening the Bond: Modern Biomaterials for Fracture Fixation and Bone Regeneration. Our global panel of surgeon advisors will discuss current hashtag#Biomaterials and their challenges, as well as plans for…
-
DTIF Project Consortium Progress Meeting
Biomaterials, Bone Adhesive, Bone Disease Solution, Bone Healing, Collaboration, Development, Government Funding, ResearchIt was fantastic to welcome the Enterprise Ireland #DTIF consortium team to our Shannon Headquarters at the start of September for a project progress meeting. Thank you to Nicholas Dunne and the DCU postgraduate team, the Dolmen Design & Innovation team, as well as Jackie FitzGerald of Enterprise Ireland for making the trip! #DTIF #disruptivetechnology…
-
PBC Biomed supports Day One Trauma Charity’s House of Lords Event
The PBC Biomed team had the pleasure of joining the volunteers, supporters and sponsors of Day One Trauma Support Charity for a reception at the House of Lords in London last week. PBC Biomed are a sponsor of this fantastic charity and their Major Trauma Awareness Week campaign. Check out their page for details on…
-
ESTROT 2024
PBC Biomed are delighted to sponsor and confirm attendance at the 8th Annual European Society of Tissue Regeneration in Orthopaedics and Traumatology (ESTROT) meeting in Helsinki, Finland next week. This year’s event will focus on: – Biomaterials: tissue regeneration, infection & treatment– Bone & Cartilage: tissue reconstruction & regeneration– Traumatology: surgical techniques, host reactions– Plastic…
-
DTIF-funded project, OsStic® technology awarded #BreakthroughDevice designation by the FDA.
Shannon, Ireland, February 12th 2024: Irish medical device company Biomimetic Innovations Ltd, an affiliate of PBC Biomed, announced ‘Breakthrough Device’ designation from the Food and Drug Administration FDA in January, for the development of a groundbreaking new bio-adhesive bone void filler technology called OsStic®. PBC Biomed leads a consortium for this development project, which is…
-
FDA grants global Medical Device company Biomimetic Innovations ‘Breakthrough Device’ designation for OsStic® Synthetic Injectable Structural Bio-Adhesive Bone Void Filler.Â
Shannon, Ireland, 19th January, 2024: Biomimetic Innovations Ltd today announced that OsStic® has been granted ‘Breakthrough Device’ designation by the FDA. The proposed indication statement for this novel new technology is; ” OsStic®Synthetic Injectable Bone Void Filler is a structural, mechanically enhanced bioadhesive for reduction, provisional fixation, or void filling of peri-articular fractures or defects…
-
Prof. Luke O’Neill showcasing our partner ZOAN Biomed
Zoan G03, a product created by our partner Zoan Biomed was showcased yesterday evening on new RTÉ show ‘Future Island’. ZoanG03 is a bioactive bone healing device. The corals’ Natural Assembly Process ensures every surface, every pore and every mineral contribute to building a living scaffold. Superior bioactivity stimulates speedy and complete acceptance by…
Search News Items
Categories
- Awards (5)
- Biomaterials (11)
- Biovet (9)
- Bone Adhesive (13)
- Bone Disease Solution (4)
- Bone Healing (10)
- Certification (1)
- Client (2)
- Collaboration (18)
- Conferences (15)
- Contract Manufacturing (2)
- Day One Trauma Charity (1)
- Development (11)
- Events (48)
- Government Funding (2)
- Lectures (6)
- Medical Devices (8)
- Medical Implants (6)
- Memphis Office (6)
- New Hire (8)
- On TV/Radio (2)
- Press Release (8)
- Publications (7)
- ReFeelNerveRepairSolution (3)
- Regenerative Medicine (11)
- Relationship-building (13)
- Research (11)
- Sports & Social (2)
- Student Placements (2)
- Uncategorized (6)
- Upcoming Events (3)
- US Office (3)